1. Home
  2. CGEN vs LCUT Comparison

CGEN vs LCUT Comparison

Compare CGEN & LCUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • LCUT
  • Stock Information
  • Founded
  • CGEN 1993
  • LCUT 1945
  • Country
  • CGEN Israel
  • LCUT United States
  • Employees
  • CGEN N/A
  • LCUT N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • LCUT Industrial Machinery/Components
  • Sector
  • CGEN Health Care
  • LCUT Consumer Discretionary
  • Exchange
  • CGEN Nasdaq
  • LCUT Nasdaq
  • Market Cap
  • CGEN 142.4M
  • LCUT 123.6M
  • IPO Year
  • CGEN 2000
  • LCUT 1991
  • Fundamental
  • Price
  • CGEN $2.25
  • LCUT $6.12
  • Analyst Decision
  • CGEN Strong Buy
  • LCUT Strong Buy
  • Analyst Count
  • CGEN 1
  • LCUT 2
  • Target Price
  • CGEN $4.00
  • LCUT $10.25
  • AVG Volume (30 Days)
  • CGEN 898.9K
  • LCUT 42.9K
  • Earning Date
  • CGEN 03-04-2025
  • LCUT 03-11-2025
  • Dividend Yield
  • CGEN N/A
  • LCUT 2.78%
  • EPS Growth
  • CGEN N/A
  • LCUT N/A
  • EPS
  • CGEN 0.02
  • LCUT N/A
  • Revenue
  • CGEN $59,852,000.00
  • LCUT $670,888,000.00
  • Revenue This Year
  • CGEN $57.27
  • LCUT $0.98
  • Revenue Next Year
  • CGEN N/A
  • LCUT $2.58
  • P/E Ratio
  • CGEN $125.59
  • LCUT N/A
  • Revenue Growth
  • CGEN 698.03
  • LCUT N/A
  • 52 Week Low
  • CGEN $1.35
  • LCUT $5.25
  • 52 Week High
  • CGEN $3.03
  • LCUT $11.68
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 81.70
  • LCUT 56.34
  • Support Level
  • CGEN $1.92
  • LCUT $5.33
  • Resistance Level
  • CGEN $2.16
  • LCUT $5.75
  • Average True Range (ATR)
  • CGEN 0.15
  • LCUT 0.30
  • MACD
  • CGEN 0.07
  • LCUT 0.03
  • Stochastic Oscillator
  • CGEN 88.90
  • LCUT 88.76

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About LCUT Lifetime Brands Inc.

Lifetime Brands Inc is a U.S. based company that designs, sources, and sells branded kitchenware, tableware, and other products used in the home and markets its products under brands such as Farberware, KitchenAid, Mikasa, and others. The company markets and sells its products principally on a wholesale basis to retailers. It also markets and sells a limited selection of its products directly to consumers through its Pfaltzgraff, Mikasa, Fred, and Friends, Built NY, and others. Its products include kitchen tools, gadgets, cutlery, dinnerware, and glassware. The segments of the company are the U.S. and International. It derives a majority of its revenue from the U.S. segment. The company derives maximum revenue from Kitchenware products.

Share on Social Networks: